InsiderFinancial

InsiderFinancial

For the past year, FLEX PHARMA INC - NASDAQ:FLKS has found itself in base mode with the exception of a handful of sharp violent upside moves accompanied with large volume as is evidenced in the Daily chart above. In addition, we can observe that FLKS presently finds itself trading above all of its important moving averages 20/50/200 DMA's, which is...

InsiderFinancial

$IDT has been one that we have traded well in the past. The stock has a history of explosive moves. Above $8.7 and we see the stock get going and we believe we will see $10 to $12 in rather short order. $IDT started climbing last week after reporting Q3 earnings. The highlight was the company in the quarter swung from a loss last year to being profitable. The...

InsiderFinancial

It's been a couple of tough months for Copper as the metal was unable to go topside of the $3 level and subsequently broke below important support at the $2.84 figure, which precipitated its recent slide down the slippery slope where we now find the Good Dr. attempting to hold its 40-Week (200 DMA) as evidenced in the Weekly chart above. While the landscape...

InsiderFinancial

After breaking-out last month (May) on meaningful volume, ZIX CORPORATION - NASDAQ:ZIXI has found itself in pull-back mode on lower volume and in the process has now filled the gap and appears to be settling-in after the powerful move higher a month ago as evidenced in the Daily chart above. While ZIXI now finds itself trading pinched between its 20 and 50...

InsiderFinancial

There's really no bullish case that we can make for oil at this time. We are already into the summer driving season and supplies continue to increase. Last night, the API reported crude oil supplies rose by 4.9 million barrels. The market was expecting a decrease of 481,000 barrels. All eyes are now focused on the 10:30 am DOE report. With crude oil back under...

InsiderFinancial

Since recapturing its 200DMA back in February, IVANHOE MINES LTD - TSX:IVN has been trending sideways and in the process, building-out a massive base as we can observe from the Daily chart above. Additionally, IVN continues to trade above all of its important moving averages 20/50/200 and remains in fine technical shape. Furthermore, if one were to zoom-out...

InsiderFinancial

After breaking-out last month (May) on nearly 8X its average daily volume and in the process reclaiming its 200 DMA, shares of WESCO AIRCRAFT HOLDINGS INC - NYSE:WAIR continue to digest the recent run in and orderly manner as well as continuing in a Flag pattern as evidenced in the Daily chart above. In addition, WAIR now finds itself trading above all of...

InsiderFinancial

After recapturing its 200 DMA back in March and subsequently vaulting from a 3 to 4 - handle, ZIOPHARM ONCOLOGY INC - NASDAQ:ZIOP has found itself in a sideways drift and appears to be building a base these past couple of months as we can observe from the Daily chart above. With the stock trading above all of its important moving averages 20/50/200 DMA's, ZIOP...

InsiderFinancial

After breaking to higher ground last month, shares of R1 RCM INC - NASDAQ:RCM have been digesting/consolidating the move in orderly fashion and now finds itself pressing the upper level and nearing a potential break for all-time highs as well as Blue Sky's as evidenced in the Daily chart above. In addition, RCM presently trades above all of its important...

InsiderFinancial

After breaking to higher ground in 1Q19 and subsequently drifting back down to its original break-out level in the upper teen's, the shares of AMARIN CORP NASDAQ: AMRN are once again starting to show signs of potentially setting-up for another attempt at loftier levels as evidenced in the Daily chart above. While AMRN presently finds itself in drift mode...

InsiderFinancial

After breaking higher in early April on large volume, Chimerix Inc. (NASDAQ:CMRX) spent the next several weeks digesting/consolidating the move before breaking higher yet again last month (May) and in the process, recapturing its 200 DMA as evidenced in the Daily chart above. With the stock presently trading above all of its important moving averages (20/50/200...

InsiderFinancial

While the action in Gold (physical metal as well as mining equities) has scared-out; worn-out and frustrated many over the past six years consolidation as evidenced in the Monthly chart above, nothing much has changed from a longer-term perspective as the yellow metal has put in three higher lows over the course of that time period and continues to set its...

InsiderFinancial

Last month (May) USA TECHNOLOGIES INC. - NASDAQ: $USAT recaptured its 200 DMA and now finds itself hovering above and maintaining the level with both a rising 20 and 50 DMA. While the 200 DMA remains in decline, the stock nevertheless appears to have weathered the worst and may just be on the road to recovery after a very difficult end of 2018 and a nasty gap...

InsiderFinancial

TECHNICAL For the past year, EMX Royalty Corporation NYSE: EMX has traded in a range between $1 - $1.50 despite all the gyrations throughout the resource and precious metals mining sector. While many Jr. mining stocks have had a tough go of it for the most part with the exception of the very strongest names within the group, EMX has held-up and continues to...

InsiderFinancial

While both Gold and Silver, the physical metals themselves, have been the recipient of a strong move this past week, there are those precious metals miners equities whom continue to display excellent technical characteristics and find themselves perched in a favorable posture. SilverCrest Metals Inc - SILV being just one that garners attention. When examining...

InsiderFinancial

After recapturing its 200 DMA last month (May), Premier Gold Mines Ltd. $PG.TO / $PIRGF has continued to grind higher trading above all of its important moving averages (20/50/200 DMA's) and now finds itself rapidly approaching and important inflection point. In addition to appearing to have put in a double-bottom at the $1.40 level on the Weekly time-frame,...

InsiderFinancial

Pieris Pharmaceuticals is a clinical-stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in a unique and transformative way. The company's clinical pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, inhaled Anticalin proteins to treat respiratory diseases,...